Real-Time, Temperature-Controlled RF Ablation
The purpose of this webinar is to support participants interested in advancing their knowledge in RF ablation practice. Participants interested in treating their patients with RF technology will be able to learn about one of the latest innovations - DiamondTemp – the Real-Time, Temperature-Controlled Ablation Technology. Variety of complex cardiac ablation procedures will be presented during the webinar and early user experience will be shared highlighting the advantages of DiamondTemp Ablation System. In addition, the results of the DIAMOND-AF global registry will be discussed and presented to the audience.
Please click on the following links to learn more about the DiamondTemp technology :
1. Advancements in RF ablation – the role of real-time temperature-controlled energy delivery
Dr Atul Verma, Southlake Regional Centre
2. Clinical Experience with Emerging New Catheter Ablation Technologies
Prof Josef Kautzner, IKEM Medical Centre
NOW FDA APPROVED:
On January 29th Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.
This webinar is supported by::
Dr Tarvinder Dhanjal
From power-controlled back to temperature-controlled RF ablation, what changed?
Prof Daniel Steven
Use of DiamondTemp in atypical atrial flutter. From lesion formation to clinical application
Dr Daniel Rodriguez
Impact of novel radiofrequency temperature-controlled system on left- and right-sided ablations
Prof Gian-Battista Chierchia
VT experience using the DiamondTemp temperature-controlled ablation system
Dr Tarvinder Dhanjal
Roundtable discussion - Ask the experts: Q&A
- To ensure that temperature accuracy and truly reliable temperature feedback are fundamental for effective lesion creation during RF ablation procedures.
- The procedural use, best practices, and advantages of DiamondTemp technology and its impact on daily clinical practice.
- Procedural efficiencies recently demonstrated by this system in the DIAMOND-AF study.
- The webinar aims to engage cardiac electrophysiologists, cardiac physiologists, cath lab nurses, cath lab managers.
Dr Tarv Dhanjal, University Hospital Coventry & Warwickshire, NHS Trust, UKDr. Dhanjal is a Consultant Cardiologist, Electrophysiologist and honorary Associate Clinical Professor of Cardiology at the University Hospital Coventry & Warwickshire; University of Warwick and was previously Clinical Lecturer in Cardiology at St. Thomas' Hospital, UK. His expertise is in complex ablations: AF ablation and VT ablation. He has won many prizes, and is a published researcher and book author. Dr Dhanjal is also a fellow of the European Society of Cardiology (ESC) and member of the Royal College of Physicians (MRCP), British Medical Association, British Cardiac Society, Heart Rythmn Society and the Medical Defence Union.
Prof Steven is the head of Electrophysiology at the University Hospital of Cologne. Prof Steven’s skills and expertise are in atrial fibrillation, heart arrhythmias and catheter ablation. He’s had recent publications in several leading medical journals, including the International Journal of Cardiology, the Journal of the American College of Cardiology, Clinical Research in Cardiology, Journal of Interventional Cardiac Electrophysiology, and the European Heart Journal.
Dr Rodriguez is a Consultant in Cardiac Electrophysiology at Hospital Doce de Octubre in Madrid. He is also the Founder, Co-Director and Coordinator of the Master´s program in Cardiovascular Emergencies at the University of Alcalá de Henares and director of numerous training courses in cardiology as well as being a lecturer at the Master´s program in Management of Complex Arrythmias at the University of Alcalá, Madrid. His research career, which has earned him the distinction of Fellow of the European Society of Cardiology, includes more than 40 scientific communications to national and international congresses and publications in the Journal of the American College of Cardiology and the European Heart Journal, amongst others.
Prof Chierchia has been Director of the Atrial Fibrillation Program at the Heart Rhythm Management Institute of the Vrije Universtair Ziekenhuis of Brussels, directed by Prof Pedro Brugada, since 2007. He completed his training at the University of Milan, Italy.